DESIGNING EFFECTIVE ADOPTIVE IMMUNOTHERAPY FOR HIGH-RISK PEDIATRIC MEDULLOBLASTOMA VIA A RATIONAL COMBINATION WITH MRI-GUIDED FOCUSED ULTRASOUND

Children'S Research Institute, Washington DC

Investigators